The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics

Stopped early · Phase 1/Phase 2

Conditions studied: Fatty Liver, Hepatic Steatosis, Diabetes Mellitus, Liver Diseases

In brief

The purpose of this study is to determine whether probiotics, bacteria that may improve liver health, can effectively treat a chronic condition in diabetics that increases fat in the liver.

Key facts

Study ID

NCT00068094

Run by

National Center for Complementary and Integrative Health (NCCIH)

People needed

30

Starts

2005-07-01

Expected to finish

2006-02-01

Last updated by the study team

2006-08-18

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Nonalcoholic fatty liver disease

You may not qualify if…

• Any cause of liver disease other than hepatic steatosis
• Diabetes
• Known or suspected cirrhosis
• Inability or unwillingness to undergo magnetic resonance procedures
• Requirement of long-term antibiotic therapy
• Pregnancy, breast-feeding, or plans to become pregnant

Where it is running

• Johns Hopkins University — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.